Hubbeling, Harper G <br/><br/>
Safety of Combined PD-1 Pathway Inhibition and Intracranial Radiation Therapy in Non-Small Cell Lung Cancer.  [electronic resource] 

 -  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer  04 2018 
 - 550-558 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1556-1380 
<br/><br/><label>Standard No.: </label>10.1016/j.jtho.2018.01.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Non-Small-Cell Lung--pathology<br/>Combined Modality Therapy--methods<br/>Cranial Irradiation--methods<br/>Female<br/>Humans<br/>Immunotherapy--methods<br/>Lung Neoplasms--pathology<br/>Male<br/>Middle Aged<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors